神州细胞(688520)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688520 神州细胞

已收盘 05-17 15:00:00

{"stockData":{"symbol":"688520","market":"SH","secType":"STK","nameCN":"神州细胞","latestPrice":46.99,"timestamp":1715929200000,"preClose":47.11,"halted":0,"volume":1404389,"delay":0,"floatShares":445000000,"shares":445000000,"eps":-0.3791,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.12,"latestTime":"05-17 15:00:00","open":46.6,"high":47.1,"low":46.18,"amount":65506000,"amplitude":0.0195,"askPrice":46.99,"askSize":41,"bidPrice":46.96,"bidSize":9,"shortable":0,"etf":0,"ttmEps":-0.3791,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1716168600000},"adr":0,"adjPreClose":47.11,"symbolType":"stock_kcb","openAndCloseTimeList":[[1715909400000,1715916600000],[1715922000000,1715929200000]],"highLimit":51.82,"lowLimit":42.4,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":445335714,"pbRate":-40.55,"roa":"--","roe":"0.0%","epsLYR":-0.89,"committee":0.013453,"marketValue":20926000000,"floatMarketCap":20926000000,"peRate":-123.951466,"changeRate":-0.0025,"turnoverRate":0.0032,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-05-20。","afterMarket":{"amount":0,"volume":0,"close":46.99,"buyVolume":1000,"sellVolume":0,"time":1715931239505,"indexStatus":"已收盘 05-17 15:30:00","preClose":47.11}},"requestUrl":"/m/hq/s/688520","defaultTab":"news","newsList":[{"id":"2435676685","title":"神州细胞-U05月15日遭主力抛售1030万元 环比增加1031.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435676685","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435676685?lang=zh_cn&edition=full","pubTime":"2024-05-15 15:19","pubTimestamp":1715757552,"startTime":"0","endTime":"0","summary":"05月15日, 神州细胞-U股价跌2.78%，报收47.25元，成交金额9914万元，换手率0.47%，振幅4.40%，量比0.79。神州细胞-U今日主力资金净流出1030万元，连续5日净流出，上一交易日主力净流出91万元，今日环比增加1031.87%。近一年数据显示，该股主力连续5日净流出后，次日下跌概率为57.14%，平均跌幅为1.37%。该股近5个交易日下跌5.97%，主力资金累计净流出3320万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入3405万元，其中净流入天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405151534588b0a5bf4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405151534588b0a5bf4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435395564","title":"百度概念盘中跳水，神州细胞-U跌0.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435395564","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435395564?lang=zh_cn&edition=full","pubTime":"2024-05-13 09:42","pubTimestamp":1715564551,"startTime":"0","endTime":"0","summary":"05月13日，百度概念盘中跳水，截至09点42分，百度概念整体指数下跌0.54%，报1021.630点。从个股上来看，该概念的成分股中，神州细胞-U跌0.04%，ST大集跌幅居前。从资金上来看，截止发稿，百度概念概念主力净流入为-6.47亿，其中赛力斯受到资金热捧，主力净流入8959.76万；拉长时间线来看，该板块近20日主力资金净流入-352.83亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513094231861ec9d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513094231861ec9d3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435645763","title":"【机构调研记录】易方达基金调研神州细胞、江苏国泰等4只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2435645763","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2435645763?lang=zh_cn&edition=full","pubTime":"2024-05-13 08:02","pubTimestamp":1715558566,"startTime":"0","endTime":"0","summary":"易方达基金成立于2001年，截至目前，资产管理规模17915.72亿元，排名1/203；资产管理规模10551.33亿元，排名1/203；管理公募基金数702只，排名3/203；旗下公募基金经理85人，排名6/203。旗下最近一年表现最佳的公募基金产品为标普信息科技LOF，最新单位净值为4.07，近一年增长43.44%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051300000548.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2435835364","title":"【机构调研记录】国联基金调研神州细胞、国博电子等6只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2435835364","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2435835364?lang=zh_cn&edition=full","pubTime":"2024-05-13 08:02","pubTimestamp":1715558541,"startTime":"0","endTime":"0","summary":"产品主要包括有源相控阵T/R组件、砷化镓基站射频集成电路等；公司参与南方资产所在中国兵装集团及其下属子公司的与国博电子产品领域相关的产品的配套研制，包括相关指挥控制装备、雷达、技术保障装备、导弹分系统、卫星导航定位应用系统、特种装备、航空航天等产品；公司在5G移动通信基站领域的产品主要为射频芯片和射频模块。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513080356875fe4c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513080356875fe4c1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434880323","title":"神州细胞：易方达基金、安信基金等多家机构于5月8日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2434880323","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2434880323?lang=zh_cn&edition=full","pubTime":"2024-05-10 16:47","pubTimestamp":1715330827,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年5月10日神州细胞发布公告称易方达基金、安信基金、国泰君安证券、国联基金于2024年5月8日调研我司。已先后于福建、浙江集采中标。神州细胞2024年一季报显示，公司主营收入6.13亿元，同比上升86.3%；归母净利润7419.74万元，同比上升148.49%；扣非净利润1.57亿元，同比上升368.26%；负债率118.47%，投资收益1.96万元，财务费用3066.57万元，毛利率96.66%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051000030339.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2434814848","title":"神州细胞-U05月10日遭主力抛售1696万元 环比增加915.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434814848","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434814848?lang=zh_cn&edition=full","pubTime":"2024-05-10 15:18","pubTimestamp":1715325529,"startTime":"0","endTime":"0","summary":"05月10日, 神州细胞-U股价跌2.45%，报收49.44元，成交金额1.48亿元，换手率0.67%，振幅3.97%，量比1.20。神州细胞-U今日主力资金净流出1696万元，上一交易日主力净流出167万元，今日环比增加915.57%。该股近5个交易日下跌0.80%，主力资金累计净流出1937万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入4768万元，其中净流入天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405101533458af00f0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405101533458af00f0a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434611086","title":"AI制药新进展：谷歌推出新一代模型 产业链一览","url":"https://stock-news.laohu8.com/highlight/detail?id=2434611086","media":"腾讯自选股","top":-1,"share":"https://www.laohu8.com/m/news/2434611086?lang=zh_cn&edition=full","pubTime":"2024-05-09 08:14","pubTimestamp":1715213647,"startTime":"0","endTime":"0","summary":"美东时间周三，谷歌DeepMind发布了新一代预测蛋白质结构的AlphaFold 3模型，能够帮助科学家更精确地针对疾病机制，从而开发出更有效的治疗药物。据太平洋证券医药，AI制药内涵丰富，主要包括：数字生物学、计算机药物发现、实验室自动化、AI 辅助临床试验等。整体而言AI技术在制药领域的应用价值主要体现在缩短试验周期、节省成本、促进新事物发现、提升试验成功概率等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509075702861ebda0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509075702861ebda0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433752966","title":"【机构调研记录】南方基金调研益丰药房、神州细胞等8只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2433752966","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2433752966?lang=zh_cn&edition=full","pubTime":"2024-05-08 08:01","pubTimestamp":1715126514,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及5月7日披露的机构调研信息，南方基金近期对8家上市公司进行了调研，相关名单如下：1）益丰药房 个股亮点：益丰转债于2024-03-27上市；子公司益丰互联网医院是基于益丰远程诊疗中心申办的一家互联网医疗机构。旗下最近一年表现最佳的公募基金产品为南方融尚再融资混合，最新单位净值为1.84，近一年增长37.41%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405080802518ae68c10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405080802518ae68c10&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431371116","title":"神州细胞：长信基金、中泰证券等多家机构于4月30日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2431371116","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431371116?lang=zh_cn&edition=full","pubTime":"2024-04-30 23:46","pubTimestamp":1714491992,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年4月30日神州细胞发布公告称长信基金、中泰证券于2024年4月30日调研我司。已先后于福建、浙江集采中标。神州细胞主营业务：专注于恶性肿瘤、自身免疫性疾病、感染性疾病和遗传病等多个治疗和预防领域的生物药产品研发和产业化。神州细胞2024年一季报显示，公司主营收入6.13亿元，同比上升86.3%；归母净利润7419.74万元，同比上升148.49%；扣非净利润1.57亿元，同比上升368.26%；负债率118.47%，投资收益1.96万元，财务费用3066.57万元，毛利率96.66%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000057747.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431366788","title":"神州细胞-U04月30日遭主力抛售1618万元 环比增加9417.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431366788","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431366788?lang=zh_cn&edition=full","pubTime":"2024-04-30 15:18","pubTimestamp":1714461486,"startTime":"0","endTime":"0","summary":"04月30日, 神州细胞-U股价涨1.10%，报收49.84元，成交金额1.02亿元，换手率0.47%，振幅2.70%，量比0.65。神州细胞-U今日主力资金净流出1618万元，上一交易日主力净流出17万元，今日环比增加9417.65%。该股近5个交易日上涨6.50%，主力资金累计净流入562万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入6812万元，其中净流入天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043015265287c2aae4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043015265287c2aae4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431501787","title":"神州细胞(688520)：八因子放量显著 24Q1扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2431501787","media":"西部证券","top":-1,"share":"https://www.laohu8.com/m/news/2431501787?lang=zh_cn&edition=full","pubTime":"2024-04-29 07:34","pubTimestamp":1714347251,"startTime":"0","endTime":"0","summary":"八因子销售放量显著，持续投入拓展产品管线。公司2023 年重组人凝血因子VIII 产品安佳因销售收入持续放量，市场占有率稳步提升，全年销售额约17.8 亿元，同比增幅超过77%。研发人员截至23 年底合计855 人，占比36.65%。盈利预测及评级：预计24-26 年公司收入分别为27.70/36.49/40.71 亿元，同比增长46.8%/31.7%/11.6%；2024 年实现扭亏为盈。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404290734158b5f4eae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404290734158b5f4eae&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430034680","title":"国金证券：给予神州细胞买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2430034680","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430034680?lang=zh_cn&edition=full","pubTime":"2024-04-28 17:54","pubTimestamp":1714298094,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司赵海春近期对神州细胞进行研究并发布了研究报告《重组八因子持续发力，单季度首次扭亏为盈》，本报告对神州细胞给出买入评级，当前股价为49.75元。维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有5家机构给出评级，买入评级5家；过去90天内机构目标均价为56.3。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042800006814.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430003694","title":"神州细胞(688520)公司点评：重组八因子持续发力 单季度首次扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2430003694","media":"国金证券股份有...","top":-1,"share":"https://www.laohu8.com/m/news/2430003694?lang=zh_cn&edition=full","pubTime":"2024-04-28 17:07","pubTimestamp":1714295228,"startTime":"0","endTime":"0","summary":"2024 年4 月25 日，公司发布公告，2024 年1 季度营收6.12 亿元，同比增长86.30%；归母净利润7419.74 万元，扣非归母净利润1.60亿元，单季度首次扭亏为盈。重组八因子安佳因增长强劲，单季扭亏，经营性现金流转正。公司自2021 年重组八因子首次获批至今，该产品2021/22/23 年分别销售1.34、10.23 和17.8 亿元，连续3 年营收高增长。1Q24 公司营收同比高增86%，亦是主要得益于八因子销售的持续增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404281707138b5d52d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404281707138b5d52d3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430751464","title":"神州细胞(688520)：1Q24净利润扭亏 关注八因子海外上市进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2430751464","media":"中国国际金融股...","top":-1,"share":"https://www.laohu8.com/m/news/2430751464?lang=zh_cn&edition=full","pubTime":"2024-04-27 08:39","pubTimestamp":1714178345,"startTime":"0","endTime":"0","summary":"1Q24 业绩符合我们预期公司公布1Q24 业绩：收入6.13 亿元，同比增长86.3%；归母净利润7419.7 万元，扭亏为盈，主系公司核心产品重组八因子快速放量，业绩符合我们预期。1Q24 公司销售费用1.25 亿元，同比增长73.4%，我们预计主系公司增加八因子和生物类似药营销力度，销售费用率20.3%，同比下滑1.5 个百分点；研发费用2.37 亿元，同比下滑4.4%，研发费用率38.7%，同比下滑36.7 个百分点。八因子出海即将落地。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042708390787b57370&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042708390787b57370&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430983242","title":"净利润连续三年下滑、市值蒸发超七成，义翘神州发生了什么？| 拆年报 读公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2430983242","media":"大河财立方","top":-1,"share":"https://www.laohu8.com/m/news/2430983242?lang=zh_cn&edition=full","pubTime":"2024-04-26 16:25","pubTimestamp":1714119903,"startTime":"0","endTime":"0","summary":"实际上，这并非义翘神州首次出现盈利下滑。在暴涨的业绩和高毛利率的支撑下，义翘神州于2021年8月走入资本市场。这意味着，过去两年义翘神州已派发红利9.38亿元。截至2023年末，为购置厂房和分配现金股利，义翘神州现金规模较2022年末减少超过10亿元，但其货币资金仍高达13.16亿元。2023年度，神州细胞工程拖欠义翘神州应收账款账面余额为889.13万元，同时计提坏账准备42.39万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261641308b565b7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261641308b565b7c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430415402","title":"神州细胞-U涨5.72%，华福证券一周前给出“买入”评级，目标价62.84元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430415402","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430415402?lang=zh_cn&edition=full","pubTime":"2024-04-26 16:16","pubTimestamp":1714119408,"startTime":"0","endTime":"0","summary":"今日神州细胞-U涨5.72%，收盘报49.75元。2024年4月18日，华福证券研究员盛丽华发布了对神州细胞的研报《23年报&24年一季报业绩预告点评：营收端持续高增长，实现扭亏为盈拐点已至》，该研报对神州细胞给出“买入”评级，认为其目标价为62.84元，现价距离目标价尚有26.31%的涨幅空间。此外，国金证券研究员赵海春，开源证券研究员余汝意近期也对该股发布了研报，同样给出“买入”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600034892.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430243875","title":"神州细胞(688520)：重组八因子持续快速放量 助推公司实现扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2430243875","media":"开源证券","top":-1,"share":"https://www.laohu8.com/m/news/2430243875?lang=zh_cn&edition=full","pubTime":"2024-04-26 15:25","pubTimestamp":1714116307,"startTime":"0","endTime":"0","summary":"公司核心产品重组八因子（安佳因）2023年销售收入持续快速增长，基本符合预期。重组Ⅷ因子国内持续快速放量，海外布局进展顺利公司重组人凝血因子VIII 产品（安佳因）2023 年销售额约17.8 亿元，同比增长77%，产品毛利率97.42%，同比增长0.53pp。公司依托具有较强竞争力的产能和成本优势，积极应对竞争加剧及各省市集采的挑战，确保安佳因在各重点省份的集采中标，实现了产品销量持续快速增长，市场占有率稳步提升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261525198b560e02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261525198b560e02&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430243077","title":"神州细胞-U04月26日获主力加仓1545万元 环比增加21971.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430243077","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430243077?lang=zh_cn&edition=full","pubTime":"2024-04-26 15:18","pubTimestamp":1714115906,"startTime":"0","endTime":"0","summary":"04月26日, 神州细胞-U股价涨5.72%，报收49.75元，成交金额1.68亿元，换手率0.77%，振幅7.35%，量比1.05。神州细胞-U今日主力资金净流入1545万元，上一交易日主力净流入7万元，今日环比增加21971.43%。|04月26日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|宗申动力|6.34%|#|神宇股份|4.54%|#|高新发展|4.16%|#|天和防务|3.80%|#|*ST恒宇|3.77%|#|科大国创|3.72%|#|文一科技|3.36%|#|浩丰科技|2.87%|#|中广天择|2.84%|#|天晟新材|2.82%|神州细胞-U所在的生物制品行业，今日主力净流入1.19亿元，行业排名36/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042615300187b27061&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042615300187b27061&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-06-22","address":"北京市通州区北京经济技术开发区科创七街31号院5号楼307","stockEarnings":[{"period":"1week","weight":-0.0496},{"period":"1month","weight":0.2594},{"period":"3month","weight":0.0316},{"period":"6month","weight":-0.0768},{"period":"1year","weight":-0.2448},{"period":"ytd","weight":-0.1277}],"companyName":"北京神州细胞生物技术集团股份公司","boardCode":"AI0027","perCapita":"48285股","boardName":"医药制造业","registeredCapital":"44533万元","compareEarnings":[{"period":"1week","weight":-0.0002},{"period":"1month","weight":0.0269},{"period":"3month","weight":0.1005},{"period":"6month","weight":0.0326},{"period":"1year","weight":-0.0435},{"period":"ytd","weight":0.0602}],"survey":"　　北京神州细胞生物技术集团股份公司是致力于研发具备差异化竞争优势生物药的创新型生物制药研发公司，专注于恶性肿瘤、自身免疫性疾病、感染性疾病和遗传病等多个治疗和预防领域的生物药产品研发和产业化。公司的主要产品为重组蛋白药物、抗体药物等。公司在发现及研发创新药的领域拥有较强的能力，自主建立了从靶点蛋白筛选到候选药物的全套创新生物药发现上游技术平台体系。","serverTime":1716114398369,"listedPrice":25.64,"stockholders":"9223人(较上一季度增加0.37%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"神州细胞(688520)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供神州细胞(688520)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"神州细胞,688520,神州细胞股票,神州细胞股票老虎,神州细胞股票老虎国际,神州细胞行情,神州细胞股票行情,神州细胞股价,神州细胞股市,神州细胞股票价格,神州细胞股票交易,神州细胞股票购买,神州细胞股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"神州细胞(688520)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供神州细胞(688520)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}